Skip to main content
. Author manuscript; available in PMC: 2022 May 4.
Published in final edited form as: J Drug Target. 2011 Dec;19(10):915–924. doi: 10.3109/1061186X.2011.623701

Figure 5.

Figure 5.

Comparison of targeted (RGDfK) and untargeted gold content by ICP-MS in (A) blood and (B) tumors of mice bearing prostate cancer xenografts at 6, 24 and 48 h post-injection. After 6 h, the RGDfK-GNRs were mostly removed from the blood, while the same was true for untargeted GNRs after 24 h.